To investigate the efficacy of TACE "bridging" in the treatment of liver transplantation patients with liver cancer beyond the Milan standard. To screen out the risk factors affecting the downstaging effect of TACE "bridging" liver cancer beyond the Milan standard, try to establish a radiomics model to predict the downstaging effect of TACE "bridging" liver cancer beyond the Milan standard, and analyze the effect of TACE "bridging" on the liver transplantation patients with liver cancer beyond the Milan standard. Risk factors for recurrence after transplantation, try to establish a TACE "bridging" related nomogram prediction model for recurrence after transplantation of liver cancer beyond Milan criteria, and evaluate the predictive performance.
正在翻译中..